ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Schweiler Resigns, President Appoints Former Massachusetts Congresswoman Margaret Heckler

January 21, 1983

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

May 1, 1998

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk

August 4, 1989

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011